Background Esophagogastric junction adenocarcinoma (EGJA) is characterized by a high recurrence rate after esophagectomy, which significantly affects patient survival. This study aimed to identify the risk factors contributing to early recurrence (ER) within 12 months after Ivor Lewis esophagectomy (ILE) in patients with EGJA. Methods A retrospective multicenter analysis was conducted across 7 high-volume Italian centers that included 594 patients with Siewert type I and II EGJAs who underwent ILE between January 2018 and December 2022. The clinicopathologic characteristics and postoperative outcomes were analyzed. ER was defined as cancer recurrence within 12 months after surgery. Univariate and multivariate analyses were performed to identify the independent risk factors for ER. Results The overall recurrence rate was 41.2% (245/594), with ER occurring in 24.4% (145/594) of patients. The 1-year overall survival rate was 87.7%, and the 1-year recurrence-free survival (RFS) rate was 70.6%. The median RFS was 32.1 months. Multivariate Cox regression analysis identified lower body mass index (hazard ratio [HR], 0.95; P =.009), poor or absent response to neoadjuvant treatment based on the Mandard classification (HR, 2.26; P =.013), and advanced stage (HR, 2.24; P <.001) as independent significant risk factors for ER in EGJA. Conclusion Identifying prognostic factors associated with ER allows for the stratification of a subgroup of patients with poor oncological outcomes who require a personalized treatment approach, distinct from the standard multimodal treatment.

Early Recurrence of Esophagogastric junction adenoCarcinoma after Surgery: a multicentre analysis of risk factors (ERECS Trial) / De Pascale, S.; Rosati, R.; Bagnardi, V.; Cossu, A.; Ferrari, G.; Frassoni, S.; Giacopuzzi, S.; Gualtierotti, M.; Moletta, L.; Morino, M.; Pallabazzer, G.; Realis Luc, M.; Rebecchi, F.; Santi, S.; Valmasoni, M.; Weindelmayer, J.; Fumagalli Romario, U.; Guerra, D. B.; Belluomini, M. A.; Carbone, F.; De Martini, P.; De Pasqual, C. A.; Gennai, A.; Grimaldi, S.; Kersik, A.; Leone, N.; Parise, P.; Sbacco, V.; Turolo, C.; Ugliono, E.. - In: JOURNAL OF GASTROINTESTINAL SURGERY. - ISSN 1091-255X. - 30:3(2026). [10.1016/j.gassur.2026.102329]

Early Recurrence of Esophagogastric junction adenoCarcinoma after Surgery: a multicentre analysis of risk factors (ERECS Trial)

Rosati R.;
2026-01-01

Abstract

Background Esophagogastric junction adenocarcinoma (EGJA) is characterized by a high recurrence rate after esophagectomy, which significantly affects patient survival. This study aimed to identify the risk factors contributing to early recurrence (ER) within 12 months after Ivor Lewis esophagectomy (ILE) in patients with EGJA. Methods A retrospective multicenter analysis was conducted across 7 high-volume Italian centers that included 594 patients with Siewert type I and II EGJAs who underwent ILE between January 2018 and December 2022. The clinicopathologic characteristics and postoperative outcomes were analyzed. ER was defined as cancer recurrence within 12 months after surgery. Univariate and multivariate analyses were performed to identify the independent risk factors for ER. Results The overall recurrence rate was 41.2% (245/594), with ER occurring in 24.4% (145/594) of patients. The 1-year overall survival rate was 87.7%, and the 1-year recurrence-free survival (RFS) rate was 70.6%. The median RFS was 32.1 months. Multivariate Cox regression analysis identified lower body mass index (hazard ratio [HR], 0.95; P =.009), poor or absent response to neoadjuvant treatment based on the Mandard classification (HR, 2.26; P =.013), and advanced stage (HR, 2.24; P <.001) as independent significant risk factors for ER in EGJA. Conclusion Identifying prognostic factors associated with ER allows for the stratification of a subgroup of patients with poor oncological outcomes who require a personalized treatment approach, distinct from the standard multimodal treatment.
2026
13-gen-2026
Inglese
Society for Surgery of the Alimentary Tract
30
3
Pubblicato
Esperti anonimi
Internazionale
Goal 3: Good health and well-being
Adenocarcinoma
Esophagectomy
Esophagogastric junction
Neoplasm recurrence
Prognosis
No
Early Recurrence of Esophagogastric junction adenoCarcinoma after Surgery: a multicentre analysis of risk factors (ERECS Trial) / De Pascale, S.; Rosati, R.; Bagnardi, V.; Cossu, A.; Ferrari, G.; Frassoni, S.; Giacopuzzi, S.; Gualtierotti, M.; Moletta, L.; Morino, M.; Pallabazzer, G.; Realis Luc, M.; Rebecchi, F.; Santi, S.; Valmasoni, M.; Weindelmayer, J.; Fumagalli Romario, U.; Guerra, D. B.; Belluomini, M. A.; Carbone, F.; De Martini, P.; De Pasqual, C. A.; Gennai, A.; Grimaldi, S.; Kersik, A.; Leone, N.; Parise, P.; Sbacco, V.; Turolo, C.; Ugliono, E.. - In: JOURNAL OF GASTROINTESTINAL SURGERY. - ISSN 1091-255X. - 30:3(2026). [10.1016/j.gassur.2026.102329]
none
30
info:eu-repo/semantics/article
262
De Pascale, S.; Rosati, R.; Bagnardi, V.; Cossu, A.; Ferrari, G.; Frassoni, S.; Giacopuzzi, S.; Gualtierotti, M.; Moletta, L.; Morino, M.; Pallabazzer...espandi
1 Contributo su Rivista::1.1 Articolo in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/198426
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact